Cargando…

Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI

To describe from a noninterventional registry (Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Acute Coronary Syndrome), the short-term ischemic and hemorrhagic outcomes in patients with non-ST elevation myocardial infarction (MI) are managed with a loading dose (LD) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollack, Charles V., Peacock, W. Frank, Bhandary, Durgesh D., Silber, Steven H., Bhalla, Narinder, Rao, Sunil V., Diercks, Deborah B., Frost, Alex, Bangalore, Sripal, Heitner, John F., Johnson, Charles, DeRita, Renato, Khan, Naeem D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664955/ https://www.ncbi.nlm.nih.gov/pubmed/32947379 http://dx.doi.org/10.1097/HPC.0000000000000243

Ejemplares similares

Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis
por: Olufade, Tope, et al.
Publicado: (2021)

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta‐Analysis
por: Kuno, Toshiki, et al.
Publicado: (2021)

Acute Pulmonary Edema and NSTEMI
por: Pilgrim, Ashley
Publicado: (2023)

European NSTEMI guidelines—return of clopidogrel?
por: Dannenberg, Lisa, et al.
Publicado: (2021)

CORONARY CONSIDERATIONS FOR THROMBOSIS IN COVID-19 NSTEMI
por: Wilbanks, David, et al.
Publicado: (2022)

Survival After MI in a Community Cohort Study Contribution of Comorbidities in NSTEMI
por: Foraker, Randi E., et al.
Publicado: (2018)

NSTEMI treatment: should we always follow the guidelines?
por: van ’t Hof, A. W. J., et al.
Publicado: (2019)

Optimal Timing of Invasive Coronary Angiography following NSTEMI
por: Mahendiran, Thabo, et al.
Publicado: (2020)

Coronary Embolism Presenting as NSTEMI in a Patient with Splenectomy
por: Al-Taweel, Omar, et al.
Publicado: (2021)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
por: Nadarajah, Ramesh, et al.
Publicado: (2023)

Navigation of a Dormant AV Fistula for PCI in a Patient With High-Risk NSTEMI
por: Friede, Kevin A., et al.
Publicado: (2020)

Multi-centre evaluation of recent troponin assays for the diagnosis of NSTEMI
por: Chenevier-Gobeaux, Camille, et al.
Publicado: (2018)

Analysis of STEMI and NSTEMI in a Community Cohort of Marijuana Users
por: Jean-Louis, Farla, et al.
Publicado: (2022)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Reduction of QTD - A Novel Marker of Successful Reperfusion in NSTEMI. Pathophysiologic Insights by CMR
por: Jensen, Christoph J., et al.
Publicado: (2015)

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Late STEMI and NSTEMI Patients’ Emergency Calling in COVID-19 Outbreak
por: Trabattoni, Daniela, et al.
Publicado: (2020)

Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
por: Kesti, Henri, et al.
Publicado: (2022)

PSAT027 An Incidentally-Discovered Retro-Cardiac Paraganglioma Presenting as NSTEMI
por: Bal, Simrun, et al.
Publicado: (2022)

Overview of the LHCb Upstream Tracker (UT)
por: Parker, William Charles
Publicado: (2016)

International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care
por: Pollack, Charles V., et al.
Publicado: (2022)

Prevalence of antiplatelet therapy in patients with diabetes
por: Miller, Shaun R, et al.
Publicado: (2005)

Predictors of Long-Term Outcome in STEMI and NSTEMI—Insights from J-MINUET
por: Lechner, Ivan, et al.
Publicado: (2020)

Association of coronary angiographic lesions and mortality in patients over 80 years with NSTEMI
por: Siddiqui, Anwar J, et al.
Publicado: (2022)

The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score
por: Wang, Ji-Xiang, et al.
Publicado: (2022)

Laboratory markers at admission to predict the presence of totally occluded culprit artery in NSTEMI
por: Yildirim, Ufuk, et al.
Publicado: (2022)

Friend or Foe: Factor XII Deficiency Discovered Incidentally during Management of NSTEMI
por: Beck, Patrick J., et al.
Publicado: (2023)

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs
por: Lv, Meina, et al.
Publicado: (2021)

Corticosteroids: way upstream
por: Riedemann, Therese, et al.
Publicado: (2010)

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk
por: Horne, Benjamin D, et al.
Publicado: (2018)

Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development
por: Žaliaduonytė-Pekšienė, Diana, et al.
Publicado: (2017)

Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature
por: Acitelli, Angelo, et al.
Publicado: (2019)

Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
por: Charach, Lior, et al.
Publicado: (2021)

Single versus Double Stenting in NSTEMI Patients with Complex Left Main Bifurcation Disease
por: Rigatelli, Gianluca, et al.
Publicado: (2022)

Retracted: The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2011)

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
por: Bangalore, Sripal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s76cisllret5s3ehbutm1c9uvp